Insider Buy/Sell Details for the Healthcare Sector — January 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1606)
Beta Bionics, Inc. (BBNX)
Mensinger Mike — Chief Product Officer
Shares
600
Price
$30.20
Total Value
$18.12K
Shares Held After
82,952
% of Holdings
0.7%
LeonaBio, Inc. (LONA)
Worthington Mark — General Counsel and CCO
Shares
876
Price
$6.88
Total Value
$6.03K
Shares Held After
13,978
% of Holdings
5.9%
LeonaBio, Inc. (LONA)
CHURCH KEVIN — CHIEF SCIENTIFIC OFFICER
Shares
876
Price
$6.88
Total Value
$6.03K
Shares Held After
20,681
% of Holdings
4.1%
LeonaBio, Inc. (LONA)
Renninger Robert — Chief Financial Officer
Shares
297
Price
$6.88
Total Value
$2.04K
Shares Held After
12,857
% of Holdings
2.3%
LeonaBio, Inc. (LONA)
Litton Mark James — Director
Shares
2,586
Price
$6.88
Total Value
$17.79K
Shares Held After
40,828
% of Holdings
6.0%
LeonaBio, Inc. (LONA)
San Martin Javier — CHIEF MEDICAL OFFICER
Shares
1,644
Price
$6.88
Total Value
$11.31K
Shares Held After
10,189
% of Holdings
13.9%
Gemini Therapeutics, Inc. (GMTX)
Khara Rahul — Chief Legal Officer
Shares
1,157
Price
$79.27
Total Value
$91.72K
Shares Held After
37,793
% of Holdings
3.0%
Gemini Therapeutics, Inc. (GMTX)
Khara Rahul — Chief Legal Officer
Shares
4,993
Price
$78.62
Total Value
$392.57K
Shares Held After
38,950
% of Holdings
11.4%
Gemini Therapeutics, Inc. (GMTX)
Khara Rahul — Chief Legal Officer
Shares
350
Price
$77.67
Total Value
$27.18K
Shares Held After
43,943
% of Holdings
0.8%
Viking Therapeutics, Inc. (VKTX)
FOEHR MATTHEW W — Director
Shares
16,000
Price
$35.11
Total Value
$561.69K
Shares Held After
132,036
% of Holdings
10.8%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Anzalone Christopher Richard — Director
Shares
5,771
Price
$66.39
Total Value
$383.14K
Shares Held After
3,792,739
% of Holdings
0.2%
Doximity, Inc. (DOCS)
Wampler Kira Scherer — Director
Shares
2,000
Price
$44.65
Total Value
$89.30K
Shares Held After
19,839
% of Holdings
9.2%
INSMED Inc (INSM)
Schaeffer Orlov S Nicole — Chief People Strategy Officer
Shares
200
Price
$177.78
Total Value
$35.56K
Shares Held After
41,754
% of Holdings
0.5%
INSMED Inc (INSM)
Schaeffer Orlov S Nicole — Chief People Strategy Officer
Shares
9,125
Price
$177.17
Total Value
$1.62M
Shares Held After
41,954
% of Holdings
17.9%
INSMED Inc (INSM)
Schaeffer Orlov S Nicole — Chief People Strategy Officer
Shares
12,832
Price
$176.08
Total Value
$2.26M
Shares Held After
51,079
% of Holdings
20.1%
INSMED Inc (INSM)
Schaeffer Orlov S Nicole — Chief People Strategy Officer
Shares
34,103
Price
$175.17
Total Value
$5.97M
Shares Held After
63,911
% of Holdings
34.8%
INSMED Inc (INSM)
Schaeffer Orlov S Nicole — Chief People Strategy Officer
Shares
31,030
Price
$174.28
Total Value
$5.41M
Shares Held After
98,014
% of Holdings
24.0%
Tarsus Pharmaceuticals, Inc. (TARS)
Whitfield Dianne C. — Chief Human Resources Officer
Shares
893
Price
$82.93
Total Value
$74.06K
Shares Held After
23,393
% of Holdings
3.7%
Tarsus Pharmaceuticals, Inc. (TARS)
Whitfield Dianne C. — Chief Human Resources Officer
Shares
835
Price
$81.90
Total Value
$68.39K
Shares Held After
24,286
% of Holdings
3.3%
Tarsus Pharmaceuticals, Inc. (TARS)
Whitfield Dianne C. — Chief Human Resources Officer
Shares
8,122
Price
$80.71
Total Value
$655.53K
Shares Held After
25,121
% of Holdings
24.4%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
3,750
Price
$38.42
Total Value
$144.06K
Shares Held After
39,760
% of Holdings
8.6%
Oscar Health, Inc. (OSCR)
Schlosser Mario — Director
Shares
137,933
Price
$15.02
Total Value
$2.07M
Shares Held After
360,215
% of Holdings
27.7%
BioAge Labs, Inc. (BIOA)
RUBIN PAUL D — Chief Medical Officer
Shares
7,433
Price
$12.85
Total Value
$95.49K
Shares Held After
0
% of Holdings
100.0%
Damora Therapeutics, Inc. (DMRA)
Firmani Lori — Chief Financial Officer
Shares
135
Price
$21.41
Total Value
$2.89K
Shares Held After
931
% of Holdings
12.7%
Damora Therapeutics, Inc. (DMRA)
Winslow Garrett — General Counsel
Shares
255
Price
$21.38
Total Value
$5.45K
Shares Held After
1,854
% of Holdings
12.1%
Damora Therapeutics, Inc. (DMRA)
Schambye Hans T. — Director
Shares
700
Price
$21.38
Total Value
$14.97K
Shares Held After
4,682
% of Holdings
13.0%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
2,595
Price
$39.57
Total Value
$102.68K
Shares Held After
12,965
% of Holdings
16.7%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
2,405
Price
$38.70
Total Value
$93.07K
Shares Held After
15,560
% of Holdings
13.4%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
4,432
Price
$40.43
Total Value
$179.19K
Shares Held After
0
% of Holdings
100.0%
GALECTIN THERAPEUTICS INC (GALT)
Jamil Khurram — Chief Medical Officer
Shares
13,055
Price
$4.20
Total Value
$54.79K
Shares Held After
46,945
% of Holdings
21.8%
GALECTIN THERAPEUTICS INC (GALT)
CALLICUTT JACK W — Chief Financial Officer
Shares
13,914
Price
$4.20
Total Value
$58.39K
Shares Held After
53,700
% of Holdings
20.6%
GALECTIN THERAPEUTICS INC (GALT)
LEWIS JOEL — Director
Shares
18,571
Price
$4.20
Total Value
$77.94K
Shares Held After
898,021
% of Holdings
2.0%
Ceribell, Inc. (CBLL)
ROBERTSON REBECCA B — Director
Shares
2,500
Price
$21.89
Total Value
$54.73K
Shares Held After
19,576
% of Holdings
11.3%
Ceribell, Inc. (CBLL)
Woo Raymond — Chief Technology Officer
Shares
6,615
Price
$21.16
Total Value
$139.97K
Shares Held After
167,317
% of Holdings
3.8%
Ceribell, Inc. (CBLL)
Woo Raymond — Chief Technology Officer
Shares
3,025
Price
$21.18
Total Value
$64.07K
Shares Held After
167,317
% of Holdings
1.8%
Ceribell, Inc. (CBLL)
Woo Raymond — Chief Technology Officer
Shares
1,472
Price
$21.29
Total Value
$31.34K
Shares Held After
167,317
% of Holdings
0.9%
PTC THERAPEUTICS, INC. (PTCT)
STEELE GLENN JR MD PHD — Director
Shares
12,000
Price
$76.35
Total Value
$916.20K
Shares Held After
18,500
% of Holdings
39.3%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
18,338
Price
$79.27
Total Value
$1.45M
Shares Held After
30,453
% of Holdings
37.6%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
5,125
Price
$78.57
Total Value
$402.67K
Shares Held After
30,453
% of Holdings
14.4%
SI-BONE, Inc. (SIBN)
Maheshwari Anshul — Chief Financial Officer
Shares
1,552
Price
$19.63
Total Value
$30.47K
Shares Held After
180,002
% of Holdings
0.9%
SI-BONE, Inc. (SIBN)
Maheshwari Anshul — Chief Financial Officer
Shares
1,729
Price
$19.67
Total Value
$34.01K
Shares Held After
181,554
% of Holdings
0.9%
SI-BONE, Inc. (SIBN)
PISETSKY MICHAEL A. — SVP, Ops & Adm/Chief Legal Ofr
Shares
1,986
Price
$19.58
Total Value
$38.88K
Shares Held After
228,436
% of Holdings
0.9%
SI-BONE, Inc. (SIBN)
PISETSKY MICHAEL A. — SVP, Ops & Adm/Chief Legal Ofr
Shares
1,436
Price
$19.68
Total Value
$28.26K
Shares Held After
230,422
% of Holdings
0.6%
SI-BONE, Inc. (SIBN)
RECUPERO ANTHONY J — President, Commercial Ops
Shares
1,729
Price
$19.64
Total Value
$33.95K
Shares Held After
264,467
% of Holdings
0.6%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
70,037
Price
$35.87
Total Value
$2.51M
Shares Held After
69,188
% of Holdings
50.3%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
46
Price
$192.40
Total Value
$8.85K
Shares Held After
43,654
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
207
Price
$190.27
Total Value
$39.39K
Shares Held After
43,700
% of Holdings
0.5%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
102
Price
$188.96
Total Value
$19.27K
Shares Held After
43,907
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
91
Price
$187.95
Total Value
$17.10K
Shares Held After
44,009
% of Holdings
0.2%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
3,125
Price
$16.08
Total Value
$50.25K
Shares Held After
315,978
% of Holdings
1.0%
Showing 1501–1550 of 1606 transactions (page 31 of 33)